ESR1 and breast cancer: On the basis of detection of ESR1 mutations in primary breast cancer using ctDNA analysis at a very low allele frequency, in contrast to a high allele frequency in metastases, it is plausible that in some tumors rare ESR1-mutant clones may be enriched by endocrine therapy [73].